SpreeHealth
Drug price

Tamoxifen: here's the fair price

This is what US pharmacies pay, on average, for tamoxifen. Use it to spot a fair cash price, and feel good about asking for one.

Lowest generic tablet or capsule

Tamoxifen 10 Mg Tablet

$3.96
pharmacy cost for 30

A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.

Your best move

Ask for generic Tamoxifen 10 Mg Tablet. Pharmacies pay about $3.96 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.

Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.

Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.

Pharmacies near you

Your ZIP and location stay in your browser. We never store them.

Every strength and form

ProductPharmacy cost30 countEffective
TAMOXIFEN 10 MG TABLETGeneric$0.13
per tablet or capsule
$3.9610/21/2026
TAMOXIFEN 20 MG TABLETGeneric$0.27
per tablet or capsule
$8.2410/21/2026

Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.

Label basics

What it is used for (FDA label)

1 INDICATIONS AND USAGE SOLTAMOX is an estrogen agonist/antagonist indicated: For treatment of adult patients with estrogen receptor-positive metastatic breast cancer ( 1.1 ) For adjuvant treatment of adult patients with early stage estrogen receptor- positive breast cancer ( 1.2 ) To reduce risk of invasive breast cancer following breast surgery and radiation in adult women with ductal carcinoma in situ (DCIS) ( 1.3 ) To reduce the incidence of breast cancer in adult women at high risk ( 1.4 ) 1.1 Metastatic Breast Cancer SOLTAMOX is indicated for the treatment of adult patients with estrogen receptor-positive metastatic breast cancer. 1.2 Adjuvant Treatment of Breast Cancer SOLTAMOX is...

Boxed warning (from the label): WARNING: UTERINE MALIGNANCIES and THROMBOEMBOLIC EVENTS Serious and life-threatening events from the use of SOLTAMOX include uterine malignancies, stroke, and pulmonary embolism [see Warnings and Precautions (5.1 , 5.2) ] . Fatal cases of each type of event have occurred. Incidence rates per 1000 women-years for these events were estimated from the National Surgical Adjuvant Breast and Bowel Project (NSABP) P-1 trial in women at high risk for breast cancer [see Clinical Studies (14.4) ] :...

Common side effects (FDA label)

6 ADVERSE REACTIONS The following serious adverse reactions are discussed below and elsewhere in the labeling: Uterine malignancies [see Boxed Warning , Warnings and Precautions (5.1) , and Clinical Studies (14.4) ] Thromboembolic events [see Boxed Warning , Warnings and Precautions (5.2) , and Clinical Studies (14.4) ] Embryo-Fetal Toxicity [see Warnings and Precautions (5.3) , and Use in Specific Populations (8.1 , 8.3) ] Liver cancer [see Warnings and Precautions (5.4) ] Most common adverse reactions: hot flashes, mood disturbances, vaginal discharge, vaginal bleeding, nausea, and fluid...

Drug interactions (from the label)

7 DRUG INTERACTIONS Anastrozole and letrozole: Should not be used in combination with tamoxifen. ( 7.1 ) Warfarin: Do not use in patients taking tamoxifen for DCIS and for reduction in breast cancer incidence in women at high risk. ( 4 ) Closely monitor coagulation indices for increased anticoagulant effect when used with tamoxifen for metastatic breast cancer or as adjuvant therapy. ( 7.2 ) 7.1 Aromatase Inhibitors Anastrozole The combination of anastrozole and tamoxifen did not demonstrate any benefit when compared to tamoxifen alone and should be avoided in all patients [see Clinical Studies (14.2) ] . In the ATAC trial, coadministration of anastrozole and tamoxifen in breast cancer...

Warnings (from the label)

5 WARNINGS AND PRECAUTIONS Uterine malignancies: Promptly evaluate abnormal vaginal bleeding in a woman with current or past tamoxifen use. ( 5.1 ) Thromboembolic events: Risk increases with coadministered chemotherapy. For treatment of breast cancer, consider risks and benefits in patients with a history of thromboembolic events. ( 5.2 ) Embryo-fetal toxicity: Can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception. ( 5.3 , 8.1 , 8.3 ) Effects on the liver: Liver cancer and liver abnormalities, some fatal, have occurred. Perform periodic liver function testing. ( 5.4 , 5.9 ) 5.1 Endometrial Cancer, Uterine Sarcoma,...

Source: FDA drug label via openFDA, label effective 2021-11-29. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.